Initially, its role as a pro-inflammatory cytokine serves to eliminate tumor antigens; however, as the cancer progresses, the polarization of naïve CD4+ T-helper cells towards pathogenic Th17 lineage releases IL-17 and also IL-6 cytokines that are important to advance tumor stage and development. This evidence concerns the gene IL17A and cancer.